Ancient Brainstem Neurons Act as a Focus Switch Against Distractions

For decades, scientists believed attention was managed primarily by the prefrontal cortex, the brain's most evolutionarily advanced region. But a new study from Johns Hopkins University challenges that view by identifying a far older attention system buried deep in the brainstem — one shared by virtually all vertebrates.

Researchers discovered a small cluster of inhibitory neurons in an ancient brainstem region that acts like a biological focus filter. These neurons appear to suppress distracting sensory information, allowing the brain to lock onto what matters most. The system is not unique to mammals — birds, fish, and frogs share it, suggesting it evolved hundreds of millions of years ago, long before complex cortical structures emerged.

To test the neurons' function, the team designed a visual attention task for mice modeled on human attention studies. Mice had to respond correctly to central visual cues while ignoring peripheral distractors. When the identified neurons were temporarily silenced, the mice became unusually distracted — a behavioral profile closely resembling ADHD. Remarkably, when the neurons were switched back on, the animals regained normal attentional control within 24 hours.

The findings, published in Nature Communications and selected as an editorial highlight, point toward a conserved neural mechanism for selective spatial attention. Senior author Shreesh Mysore noted that the distractibility seen when these neurons are silenced mirrors a hallmark feature of ADHD in humans, raising the possibility that this circuit could be a novel therapeutic target.

For health-conscious readers, this research matters because attention, cognitive control, and distraction filtering are central to mental performance and long-term brain health. Conditions like ADHD affect millions of adults and are linked to poorer life outcomes. Understanding the ancient roots of attention could eventually yield treatments that are more targeted, with fewer side effects than current stimulant-based medications. The work remains in early animal-model stages, but the evolutionary breadth of the finding suggests strong human relevance.